glycopeptide antibiotic
Vancomycin
Answer
Vancomycin is authorised or registered in the US, the UK, Canada, Australia, Switzerland, Brazil, Serbia, Singapore and Turkey: 9 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 738 registered trials, 132 of them running. Brand names on the FDA label register: Vancomycin Hydrochloride, Vancomycin, Vancomycin Hydrochloride For Oral Solution and Firvanq.
RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
738 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 149 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 368 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Not on the register | EMA, ema | 2026-08-31 |
| United Kingdom | Authorised | MHRA, uk-mhra | 2026-10-03 |
| Canada | Authorised | Health Canada, ca-dpd | 2026-10-03 |
| Australia | Registered | TGA, au-artg | 2026-10-03 |
| Switzerland | Authorised | Swissmedic, ch-swissmedic | 2026-10-03 |
| Brazil | Registado | ANVISA, br-anvisa | 2026-10-03 |
| Serbia | Authorised | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Registered | HSA, sg-hsa | 2026-09-03 |
| Turkey | Ruhsatli | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Vancomycin changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 738 trials
| NCT02764359 | Study of Obese Patients Comparing Two Vancomycin Loading Dose Regimens completed · register updated 2026-10-01 |
|---|---|
| 2025-520452-28-00 | Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II tr no status recorded · register updated 2026-09-30 |
| NCT03765567 | Placement of Antibiotic Powder in Wounds During the Emergency Room currently recruiting participants · register updated 2026-09-30 |
| NCT04731025 | Local Antibiotics for Breast Implants running, but no longer enrolling · register updated 2026-09-29 |
| NCT05539729 | Vancomycin Study in Multiple Sclerosis (MS) currently recruiting participants · register updated 2026-09-28 |
| 2024-510921-25-00 | Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial no status recorded · register updated 2026-09-25 |
| NCT06772675 | Vancomycin Reduction Practices (VRP) in the NICU currently recruiting participants · register updated 2026-09-24 |
| NCT07328971 | Vancomycin Taper to Prevent Recurrent Clostridioides Difficile currently recruiting participants · register updated 2026-09-23 |
| NCT06426836 | Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO) currently recruiting participants · register updated 2026-09-21 |
| 2026-525632-41-00 | Randomized Controlled Trial Assessing the Effectiveness and Safety of Fecal Microbiota Transfer for VRE Eradication in Immunocompr no status recorded · register updated 2026-09-18 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.